Barriers to SARS-CoV-2 Testing among U.S. Employers in the COVID-19 Pandemic: A Qualitative Analysis Conducted January through April 2021
Authors:
- Alberto J. Caban-MartinezAlberto J. Caban-Martinez
- Claudia ParvantaCPClaudia Parvanta
- Naciely CabralNCNaciely Cabral
- Cynthia K. BallCBCynthia K. Ball
- Adrienne EastlakeAEAdrienne Eastlake
- Jeffrey L. LevinJLJeffrey L. Levin
- Kevin MooreKMKevin Moore
- Dalia NessimDNDalia Nessim
- Ernie StracenerESErnie Stracener
- Matthew S. ThieseMatthew S. Thiese
- Paul A. SchultePSPaul A. Schulte
Open Access
- 19 September 2022
- journal article
- research article
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 19 (18) , 11805
Abstract
During the first year of the COVID-19 pandemic, U.S. companies were seeking ways to support their employees to return to the workplace. Nonetheless, the development of strategies to support the access, use, and interpretation of SARS-CoV-2 testing was challenging. In the present study, we explore, from the perspective of owners and company leadership, the barriers to SARS-CoV-2 testing among U.S. companies. Key informant interviews with company representatives were conducted during January–April 2021 about SARS-CoV-2 testing. A pre-interview survey assessed respondent socio-demographic and organizational characteristics. Interview sessions were transcribed, coded, and analyzed using MaxQDA. A total of twenty interviews were completed with at least two interviews conducted in each major U.S. industry sector. Ninety percent of participants represented companies in business >10 years, comprising both small and large workforces. Using a grounded theory approach, six themes emerged: (1) access to and knowledge of SARS-CoV-2 tests; (2) strategies for symptomatic and asymptomatic testing of workers; (3) type/availability of personal protective equipment to mitigate coronavirus exposures; (4) return-to-work policies; (5) guidance and communication of SARS-CoV-2 Testing; and (6) use of contact tracing and SARS-CoV-2 vaccination. Various modifiable and non-modifiable challenges for SARS-CoV-2 testing among U.S. companies were identified and can inform work-related SARS-CoV-2 testing strategies.Keywords
Funding Information
- CDC/NIOSH Intergovernmental Personnel Act (IPA)
This publication has 21 references indexed in Scilit:
- The Need for More and Better Testing for COVID-19JAMA, 2020
- Compounded inequality: how the U.S. Paycheck Protection Program is failing Los Angeles Latino small businessesEthnic and Racial Studies, 2020
- COVID-19 testing and infection surveillance: Is a combined digital contact-tracing and mass-testing solution feasible in the United States?Cardiovascular Digital Health Journal, 2020
- Small business awareness and adoption of state-of-the-art technologies in emerging and developing markets, and lessons from the COVID-19 pandemicJournal of Small Business & Entrepreneurship, 2020
- The impact of COVID-19 on public space: an early review of the emerging questions – design, perceptions and inequitiesCities & Health, 2020
- Update: COVID-19 Among Workers in Meat and Poultry Processing Facilities ― United States, April–May 2020MMWR. Morbidity and Mortality Weekly Report, 2020
- Covid-19 and the Need for Health Care ReformNew England Journal of Medicine, 2020
- Using Zoom Videoconferencing for Qualitative Data Collection: Perceptions and Experiences of Researchers and ParticipantsInternational Journal of Qualitative Methods, 2019
- Rapid and Rigorous Qualitative Data AnalysisInternational Journal of Qualitative Methods, 2017
- Grounded Theory in Global PerspectiveQualitative Inquiry, 2014